Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rofil PIPs implanted in 61 women post-Dutch warning, Estonia survey reveals

This article was originally published in Clinica

Executive Summary

At least 61 women received Rofil-rebranded PIP breast implants in Estonia as recently as 2011, the country’s healthcare products regulatory agency, Terviseamet, has announced. The figure is among the results of a survey it has conducted on the use of PIP and Rofil ‘M-implant’ devices among the country’s 13 cosmetic surgery providers.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT098611

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel